3320 — China Resources Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$28.93bn
- HK$167.93bn
- CNY269.57bn
Brief: Pfizer Investment to Jointly Commercialize Cancer Drugs with China Resources Pharmaceutical
Brief: China Resources Pharmaceutical CR Sanjiu To Sell 51% Interest In CR Shenghuo For RMB1.79 Bln
Brief: China Resources Pharmaceutical Posts 9M Net Profit For Jiangzhong Pharmaceutical RMB683.9 Mln
Brief: China Resources Pharmaceutical Posts 9M Results For China Resources Double-Crane Pharmaceutical
Brief: China Resources Pharmaceutical Posts 9M Revenue For CR Boya Bio-Pharmaceutical Of RMB 1.25 Bln
Brief: China Resources Pharmaceutical Says CR Jiangzhong To Increase Shareholding
Brief: China Resources Pharmaceutical Updates On 9M Profit Estimates For Dong-E-E-Jiao
China Resources Pharma drops as retail unit plans to shut Hong Kong operations
Brief: China Resources Pharmaceutical Group Posts H1 Net Income Of RMB 5,540.6 Million
Brief: China Resources Pharmaceutical Posts HY Net Profit Attributable For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Group Says HY Revenue Rmb2.17 Billion For Jiangzhong Pharmaceutical
Brief: China Resources Pharmaceutical Says HY Net Profit Attributable RMB738.4 Mln For Dong-E-E-Jiao
Brief: China Resources Pharmaceutical Announces Proposed Acquisition Of Green Cross HK
Brief: China Resources Pharmaceutical Says Dong-E-E-Jiao Sees HY Net Profit Attributable To Range From Approximately Rmb695 Million To Rmb760 Million
Brief: China Resources Pharmaceutical Says Proposed Internal Reorganization
Brief: China Resources Pharmaceutical Group Says CR Sanjiu Entered Into Cooperation Agreement With CR Power
Brief: China Resources Pharmaceutical Says Completion Of CR Zizhu's Proposed Internal Reorganization
Brief: China Resources Pharmaceutical's Unit Receives Approval For Public Issuance Of Corporate Bonds
Brief: China Resources Pharmaceutical Says Dong-E-E-Jiao Sees QTRLY Net Profit Attributable From Rmb334 Million To Rmb357 Million